QA: RENOVARO BIOSCIENCES INC. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001527728_2020_RENOVARO_BIOSCIENCES_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001527728')"}

Graph

Absolute values for 0001527728, RENOVARO BIOSCIENCES INC.

  xvar xval
0 AssetsCurrent 12,494,987
1 IntangibleAssetsNetIncludingGoodwill 11,733,299
2 PropertyPlantAndEquipmentNet 687,517
3 remainder_Assets 154,961,550
4 LiabilitiesCurrent 1,110,416
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 5,667,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,271,540
9 ResearchAndDevelopmentExpense 2,498,107
10 remainder_Expenses 220,385
11 remainder_Revenues 0
12 remainder_NetIncome -7,026,448
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 179,877,353
1 Liabilities 6,777,416
2 Expenses 10,990,032
3 Revenues 0
4 StockholdersEquity 173,099,937
5 NetIncome -18,016,480
6 ComprehensiveNetIncome -18,016,480
7 BaseVar 102,335,624
8 EconomicCapitalRatio 3.00

Edgar->Model Mapping

Feature Distribution

Change over Time